Posted in Flagyl on January 8, 2015

Evaluating the effectiveness and safety of nitazoxanide in simile to standard treatment in
patients through grade II-III hepatic encephalopathy (HE). Also, Evaluating the validity of
administering nitazoxanide on the progress of patient‘s quality of life.

Clinical Trial Conditions: Hepatic Encephalopathy

Treatments in this Clinical Trial : Nitazoxanide, Oral lactulose, Metronidazole, Rifaximine

Clinical Trial Phase: Phase 2

Eligible Clinical Trial Participant Age : Between 18 years to 65 years

Can Healthy Volunteers Participate: No

Clinical Trial Lead Sponsor: Ain Shams University

Detailed Clinical Trial Description: Evaluating the efficacy and safety of nitazoxanide in compare to standard treatment in
patients through grade II-III hepatic encephalopathy (HE). Also, Evaluating the weight of
administering nitazoxanide on the amendment of patient‘s quality of life.

The clinical unhappiness information was obtained from http://clinicaltrials.gov/ct2/disclose/NCT02334163

Osteoporosis is a major notorious health problem as a result of associated feebleness fractures.